.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Cerilliant
Johnson and Johnson
Dow
Harvard Business School
Queensland Health
Teva
US Army
Covington
Accenture

Generated: September 22, 2017

DrugPatentWatch Database Preview

RIMANTADINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Rimantadine Hydrochloride, and what generic Rimantadine Hydrochloride alternatives are available?

Rimantadine Hydrochloride is a drug marketed by Impax Labs Inc, Impax Labs, and Actavis Elizabeth. and is included in three NDAs.

The generic ingredient in RIMANTADINE HYDROCHLORIDE is rimantadine hydrochloride. There are three drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the rimantadine hydrochloride profile page.

Summary for Tradename: RIMANTADINE HYDROCHLORIDE

Patents:0
Applicants:3
NDAs:3
Suppliers / Packagers: see list5
Bulk Api Vendors: see list82
Clinical Trials: see list2,282
Patent Applications: see list706
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RIMANTADINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: RIMANTADINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs Inc
RIMANTADINE HYDROCHLORIDE
rimantadine hydrochloride
TABLET;ORAL075916-001Nov 2, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Labs
RIMANTADINE HYDROCHLORIDE
rimantadine hydrochloride
TABLET;ORAL076132-001Aug 30, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
RIMANTADINE HYDROCHLORIDE
rimantadine hydrochloride
TABLET;ORAL076375-001Jan 14, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Argus Health
US Department of Justice
Merck
Novartis
Dow
Federal Trade Commission
Johnson and Johnson
Julphar
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot